JLL Report: 2023 Life Sciences Industry and Real Estate Perspective
Recently, JLL released a report titled, “2023 Life Sciences Industry and Real Estate Perspective: Assessing the future landscape for biopharma, medtech and biomanufacturing” that explores the real estate landscape of technology sectors. According to data captured in the LevinPro HC database, JLL has advised on 24 transactions in 2023. Of those, there were 19 medical office buildings, two inpatient behavioral health hospitals, one ambulatory surgery center and one acute care facility. In total, the 50 facilities consist of more than 4.2 million square feet. The report was broken down into multiple sections that looked at various elements of the market. Below, we’ve summarized each... Read More »
Epic Staffing Group Announces First Acquisitions of the Year
Epic Staffing Group, a portfolio company of The Pritzker Organization, L.L.C., announced on November 2 that it acquired two companies. SBG Healthcare is a physician staffing firm focused on the placement of advanced practitioners and physicians in operating rooms and surgical suites. It is based in Hollywood, Florida and was established in 2013. According to data captured in the LevinPro HC database, this transaction represents the 28th healthcare staffing acquisition of the year. Chicago Telerad is a provider of diagnostic imaging and teleradiology services for hospitals and radiology groups. Founded in 2017, it is based in South Barrington, Illinois. According to data in... Read More »
CVS Health Scores with $2.2 Billion in Q3 Profit Amid Layoffs and Acquisitions
CVS Health (NYSE: CVS) released its Q3:23 operating results on Wednesday, November 1, 2023. The company reported net income of $2.2 billion, or $1.75 per share, thanks to double-digit percentage sales growth across all the company’s businesses and contributions from its new healthcare services acquisitions. This compares to the net loss of $3.4 billion, or $2.59 per share, announced in the same quarter last year when the company recorded $5 billion in opioid-related litigation charges. The giant drugstore chain has spent nearly $20 billion this year on acquisitions. First, the company added senior primary care centers via its acquisition of Oak Street Health for $10.6 billion in February.... Read More »
Resolian Acquires Denali Medpharma
Resolian, a portfolio company of Ampersand Capital Partners, announced that it acquired Denali Medpharma. Denali Medpharma is a Chinese bioanalytical contract research organization (CRO). It is well known as the industry leader in China in the bioanalysis of oligonucleotide drugs and mRNA vaccines, liposomal drug, ultra-sensitive assays for inhalation drugs and biomarker assays. Resolian (formerly Alliance Pharma Inc. and Drug Development Solutions Ltd.) is a CRO that specializes in advanced bioanalytical research services for small and large molecule drugs. It also specializes in drug metabolism studies to support pharmaceutical and biotechnology companies’ drug... Read More »
